Page 1 of Clinical Trials for Multi-Kinase Inhibitor, 39 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
Last Updated: March 14, 2012
Condition(s): Head and Neck Neoplasms; Pheochromocytoma; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell
2
Recruiting
AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia
Last Updated: April 7, 2012
Condition(s): Leukemia
3
Active, not recruiting
Study Adding Multikinase Inhibitor Sorafenib to Existing Endocrine Therapy in Patients With Advanced Breast Cancer
Last Updated: September 23, 2011
Condition(s): Breast Cancer
4
Completed
Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI
Last Updated: May 15, 2012
Condition(s): Colorectal Neoplasms
5
Recruiting
Vandetanib With Everolimus
Last Updated: May 14, 2012
Condition(s): Advanced Cancers
6
Terminated
Depocyt® With Sorafenib in Neoplastic Meningitis
Last Updated: March 27, 2012
Condition(s): Neoplastic Meningitis
7
Recruiting
AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors
Last Updated: April 7, 2012
Condition(s): Unspecified Childhood Solid Tumor, Protocol Specific
8
Recruiting
Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)
Last Updated: December 15, 2011
Condition(s): Hepatocellular Carcinoma
9
Active, not recruiting
Phase 1b Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Breast Cancer
Last Updated: January 20, 2011
Condition(s): Locally Recurrent and Metastatic Breast Cancer
10
Terminated
A Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC)
Last Updated: September 29, 2011
Condition(s): Carcinoma, Non-Small-Cell Lung
11
Active, not recruiting
Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST)
Last Updated: May 3, 2012
Condition(s): Gastrointestinal Stromal Tumors
12
Active, not recruiting
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study
Last Updated: September 1, 2011
Condition(s): Non-Small Cell Lung Cancer
13
Recruiting
Sorafenib With Capecitabine and Oxaliplatin for Advanced or Metastatic Hepatocellular Carcinoma
Last Updated: September 12, 2008
Condition(s): Advanced Hepatocellular Carcinoma; Metastatic Hepatocellular Carcinoma
14
Not yet recruiting
Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer
Last Updated: January 3, 2012
Condition(s): Breast Cancer; Metastatic Breast Cancer; Stage IV Breast Cancer
15
Recruiting
Dovitinib for Imatinib/Sumitinib-failed Gastrointestinal Stromal Tumors (GIST)
Last Updated: September 26, 2011
Condition(s): Gastrointestinal Stromal Tumors
16
Recruiting
The Treatment of Lapatinib in Combination With Sorafenib in Patients With Advanced Refractory Solid Tumors
Last Updated: September 1, 2010
Condition(s): Solid Tumors
17
Not yet recruiting
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Last Updated: April 15, 2012
Condition(s): Neuroblastoma Recurrent
18
Recruiting
Carbon Ion Radiotherapy for Hepatocellular Carcinoma
Last Updated: August 3, 2011
Condition(s): Hepatocellular Carcinoma
19
Not yet recruiting
Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency
Last Updated: March 23, 2011
Condition(s): Hepatocellular Carcinoma
20
Active, not recruiting
Letrozole Plus Oral Cyclophosphamide Plus/Minus Sorafenib as Primary Systemic Treatment in Breast Cancer Patients
Last Updated: August 6, 2009
Condition(s): Breast Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Multi-Kinase+Inhibitor

Page 1 of Clinical Trials for Multi-Kinase Inhibitor, 39 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About